Westfield Capital Management’s Ligand Pharmaceuticals LGND Stock Holding History

Bought
Maintained
Sold
Quarter Market Value Status Shares Shares
Change %
Capital Flow Portfolio Weight Portfolio Position
2013
Q4
Sell
-10,900
Closed -$294K 337
2013
Q3
$294K Hold
10,900
﹤0.01% 329
2013
Q2
$254K Buy
+10,900
New +$254K ﹤0.01% 338